ACH
GH icon

ArrowMark Colorado Holdings’s Guardant Health GH Stock Holding History

ArrowMark Colorado Holdings’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-25,500
Closed -$2.2M – 326
2019
Q2 		$2.2M Buy
25,500
+250
+1% +$19.1K 0.02% 240
2019
Q1 		$1.94M Sell
25,250
-71,825
-74% -$3.98M 0.02% 246
2018
Q4 		$3.65M Buy
+97,075
New +$3.58M 0.04% 236

Other funds holding GH

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VS
VK Services Menlo Park, California $1.01M AUM 157.81% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $31.9B AUM 28.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ArrowMark Colorado Holdings's GH Position: Q3 2019 in Review

ArrowMark Colorado Holdings sold out of Guardant Health (GH) in Q3 2019, closing a stake of 25,500 shares — an estimated $2.2M sold.

ArrowMark Colorado Holdings first reported a position in GH in Q4 2018 and held it in 3 quarters. The position peaked at $3.65M in Q4 2018. 242 funds tracked by Wall St. Rank hold GH as of Q3 2019.

  • ArrowMark Colorado Holdings reported no remaining Guardant Health position as of Q3 2019 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 25,500 Guardant Health shares in Q3 2019, an estimated $2.2M.
  • ArrowMark Colorado Holdings first reported a position in Guardant Health in Q4 2018 and held it in 3 quarters.
  • ArrowMark Colorado Holdings's Guardant Health position peaked at $3.65M in Q4 2018.
  • 242 funds tracked by Wall St. Rank held Guardant Health as of Q3 2019.

Based on ArrowMark Colorado Holdings's 13F filing for Q3 2019, filed 14 Nov 2019.